Drug Cos. Tell 3rd Circ. To Affirm Eye Drop Suit Dismissal
Pfizer, Merck and others urged the Third Circuit on Wednesday not to revive litigation accusing the drugmakers of boosting prescription eye drop sales by using bottles that dispensed bigger-than-needed drops, contending that...To view the full article, register now.
Already a subscriber? Click here to view full article